Cleared Traditional

K893977 - GRAM NEGATIVE AND POSITIVE MIC/COMBO PANELS (FDA 510(k) Clearance)

Aug 1989
Decision
74d
Days
Class 2
Risk

K893977 is an FDA 510(k) clearance for the GRAM NEGATIVE AND POSITIVE MIC/COMBO PANELS. This device is classified as a Manual Antimicrobial Susceptibility Test Systems (Class II - Special Controls, product code JWY).

Submitted by Baxter Healthcare Corp (West Sacramento, US). The FDA issued a Cleared decision on August 15, 1989, 74 days after receiving the submission on June 2, 1989.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K893977 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 1989
Decision Date August 15, 1989
Days to Decision 74 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code JWY — Manual Antimicrobial Susceptibility Test Systems
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices — JWY Manual Antimicrobial Susceptibility Test Systems

All 28
MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL
K252114 · Liofilchem S. R. L. · Oct 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
K252062 · Thermo Fisher Scientific · Sep 2025
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL
K250575 · Thermo Fisher Scientific · Sep 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
K252014 · Thermo Fisher Scientific · Aug 2025
MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)
K251580 · Liofilchem S. R. L. · Aug 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
K250990 · Thermo Fisher Scientific · Jun 2025